Waterside Pharmaceuticals is a UK life sciences and agriculture business based in Aberdeenshire. We bring controlled environment cultivation, regulated distribution and clinical services together with one purpose: safer, more consistent and more affordable access to cannabis based medicines for the patients who may benefit from them.
Inside a Waterside flower room, Aberdeenshire
A natural medicine, refined by science and held to pharmaceutical standards.
Our work begins with the plant and ends with the patient. In between sits a controlled, documented and quality led process built to support consistency, traceability and trust at every step of the supply chain.
Controlled environment cultivation in Aberdeenshire, designed around consistency, traceability and quality led production.
Explore →
Regulated distribution under a Wholesale Distribution Authorisation, built around Good Distribution Practice and product integrity.
Explore →
Waterside Health, our separate clinical platform supporting patients and healthcare professionals through specialist led care.
Explore →
Waterside is grounded in a single place and a long term mindset. We are developing UK cultivation capability to support supply resilience, greater consistency and a more transparent route from plant production to regulated medicinal use.
Waterside Pharmaceuticals is a hybrid life sciences and agriculture company based in Aberdeenshire, Scotland, developing a regulated medicinal cannabis business designed for the UK's growing need for safe, consistent and quality led cannabis based medicines.
The north east of Scotland, home to Waterside
Our work brings together controlled environment cultivation, pharmaceutical distribution, clinical services and long term investment in people, systems and innovation. We believe the future of medicinal cannabis in the UK depends on trust. That means robust quality systems, transparent supply chains, responsible clinical governance, and products handled with care from cultivation through to patient access.
Waterside has been built by a team with experience across regulated industries, quality assurance, supply chain, controlled environment agriculture, engineering, healthcare, legal, commercial operations and business growth.
Our mission is to deliver safe, efficacious and affordable medicine that transforms the lives of patients.
Medicinal cannabis is an emerging area of UK healthcare, and confidence matters to patients, clinicians and partners alike. We are working to support that confidence through regulated operations, high standards and careful governance, rather than moving quickly at the expense of quality.
Every part of our operation is designed around strong quality systems, documented processes, staff training, traceability and continuous improvement.
Our long term purpose is to improve access to regulated cannabis based medicines where specialist clinicians consider them appropriate.
We are interested in plant science, cultivation data, product consistency, terpene and cannabinoid profiles, and how controlled environments support reliable outcomes.
We operate in a highly controlled sector and take our responsibilities seriously across security, compliance, distribution, cultivation and communications.
We are committed to building a business that considers energy use, resource efficiency, environmental impact and long term resilience.
We are not here to move quickly at the expense of quality. We are here to build properly.
By combining clinical rigour with responsible cultivation and distribution, Waterside is working to bring medical cannabis into the light: credible, human and trusted.
A multidisciplinary team bringing practical start up experience, regulated sector discipline and a shared commitment to building a responsible UK medicinal cannabis business focused on quality, patient safety and long term impact.
Founder of Waterside, with significant experience building, scaling and leading high growth businesses. Martin focuses on the overall vision, strategy and long term development of Waterside, including investment, innovation, partnerships and the creation of a sustainable UK medicinal cannabis platform.
Morag leads operational development across Waterside, helping translate strategy into controlled, compliant and practical systems. Her work spans site operations, quality management, supply chain planning, commercial readiness, regulatory implementation and future capacity planning.
Graeme supports Waterside across legal, regulatory and governance matters, including legal strategy, commercial agreements, regulatory applications, controlled drugs compliance and risk management. His work helps ensure growth is supported by strong governance and clear legal foundations.
Lewis leads financial strategy and commercial planning, supporting investment planning, financial modelling, capital allocation, budgeting and forecasting. He works closely with the leadership team to keep plans financially robust, sustainable and aligned with long term growth.
Neil brings significant commercial, financial and international growth experience. Formerly Chief Financial Officer at BrewDog and a long standing board member during a period of substantial global expansion, he supports strategic planning, commercial development and financial discipline as Waterside scales.
The Waterside team is united by a clear purpose. We combine expertise from healthcare, agriculture, quality, operations, law, finance and commercial development to build a platform that is governed properly and designed for the long term.
At Waterside, cultivation is more than growing plants. It is a controlled, documented and quality led process designed to support consistency, traceability and patient safety.
A flowering canopy under full environmental control
Our facility in Aberdeenshire has been upgraded for medicinal cannabis cultivation, including dedicated flower rooms, a mother room, drying areas and environmental control systems. These systems allow us to manage temperature, humidity, lighting, airflow and plant nutrition in a controlled indoor environment.
This level of control matters because cannabis is a complex plant. Genetics, environmental conditions, harvest timing, drying, storage and processing can all influence the final material. By managing these variables carefully, we support consistent quality and reliable product characteristics.
The mother room, where genetics are maintained
Indoor controlled environment cultivation lets us monitor and refine the conditions that influence plant development, yield, cannabinoid profile, terpene expression and overall product quality.
Cultivation is supported by documented procedures, staff training, batch records, environmental monitoring, cleaning controls and quality oversight.
From plant material through to harvest and onward handling, robust records support quality assurance, regulatory compliance and supply chain integrity.
We study how genetics, varieties, grow media, nutrition, environmental settings, harvest windows and drying conditions influence the final material.
Cultivation is an active process of learning, monitoring and refinement, using operational data and team experience to improve over time.
A transparent route from plant production to regulated medicinal use.
Our aim is to contribute to a stronger UK medicinal cannabis supply chain by producing high quality starting material under controlled conditions, supporting improved supply resilience and greater consistency.
Cultivation enquiries →Waterside Pharmaceuticals holds a Wholesale Distribution Authorisation and is developing its distribution operations to support the supply of unlicensed cannabis based products for medicinal use in humans.
Our distribution model is designed around Good Distribution Practice, product integrity, secure handling and regulatory compliance. In practice, this means appropriate supplier and customer qualification, controlled storage, documented procedures, trained personnel, traceability, quality checks and secure movement of goods.
Distribution is a critical part of patient access. Even when a product has been manufactured to the right standard, it must continue to be handled correctly throughout the supply chain. Storage, temperature control, documentation, transport and verification all matter.
We work to ensure products are sourced, handled and supplied through appropriate, authorised and qualified routes.
Clear records support the ability to trace products, batches, suppliers, customers and onward movement through the supply chain.
Medicinal cannabis products require careful control. Our processes support secure storage, appropriate access controls and responsible handling.
Good Distribution Practice underpins how medicinal products are stored, transported and supplied, and our systems are developed to support these expectations.
We supply only through appropriate professional channels and in line with applicable legal and regulatory requirements.
Waterside is interested in building relationships with appropriate industry partners, clinics, pharmacies, manufacturers and healthcare organisations. For distribution related enquiries, please contact our team.
Let us talk about working together.
Make a distribution enquiry →Waterside Health is our separate clinical platform, developed to support patients and healthcare professionals through specialist led medical cannabis services.
The clinic sits separately from Waterside Pharmaceuticals and provides information for patients, healthcare professionals and wider industry contacts who wish to register their interest. Waterside Health supports responsible clinical access to cannabis based medicines where a specialist clinician considers this appropriate as part of an individual patient's care.
The clinical service is separate from our cultivation and distribution operations, with its own governance, patient pathways and healthcare focus.
Visit Waterside Health →For general enquiries, partnership opportunities, distribution discussions or media requests, please contact the Waterside Pharmaceuticals team. We welcome conversations with healthcare professionals, pharmacies, clinics, manufacturers, suppliers, researchers, local partners and organisations interested in the future of regulated medicinal cannabis in the UK.